Total Payments
$165,601
2024 Payments
$49,431
Companies
42
Transactions
553
Medicare Patients
5,493
Medicare Billing
$391,623
Payment Breakdown by Category
Other$146,751 (88.6%)
Food & Beverage$13,650 (8.2%)
Travel$5,200 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $146,751 | 71 | 88.6% |
| Food and Beverage | $13,650 | 453 | 8.2% |
| Travel and Lodging | $5,200 | 29 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42,265 | 69 | $0 (2024) |
| Lilly USA, LLC | $39,160 | 39 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $36,740 | 32 | $0 (2022) |
| Boston Scientific Corporation | $28,903 | 58 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $11,040 | 33 | $0 (2024) |
| Amgen Inc. | $762.59 | 44 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $753.92 | 35 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $588.05 | 44 | $0 (2024) |
| Medtronic Vascular, Inc. | $533.47 | 6 | $0 (2019) |
| Merck Sharp & Dohme LLC | $512.78 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49,431 | 108 | Boston Scientific Corporation ($25,964) |
| 2023 | $11,631 | 71 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,871) |
| 2022 | $17,976 | 77 | Lilly USA, LLC ($8,765) |
| 2021 | $23,624 | 44 | Boehringer Ingelheim Pharmaceuticals, Inc. ($14,510) |
| 2020 | $10,974 | 37 | Lilly USA, LLC ($6,547) |
| 2019 | $31,283 | 89 | SANOFI-AVENTIS U.S. LLC ($24,917) |
| 2018 | $16,092 | 60 | SANOFI-AVENTIS U.S. LLC ($9,195) |
| 2017 | $4,591 | 67 | SANOFI-AVENTIS U.S. LLC ($2,608) |
All Payment Transactions
553 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $101.71 | General |
| Category: Cardiovascular | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.97 | General |
| Category: DIABETES | ||||||
| 12/05/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $20.76 | General |
| Category: Medical Device | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| Category: WATCHMAN_IC | ||||||
| 12/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/11/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $37.07 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 11/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $140.12 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Obesity | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.41 | General |
| Category: Cardiovascular | ||||||
| 10/17/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| Category: WATCHMAN_IC | ||||||
| 10/14/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $43.00 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 10/14/2024 | Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $43.00 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $108.12 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 09/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $1.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 1,261 | 1,733 | $161,545 | $104,736 |
| 2022 | 6 | 1,363 | 1,867 | $168,395 | $108,334 |
| 2021 | 6 | 1,591 | 2,003 | $171,740 | $109,821 |
| 2020 | 7 | 1,278 | 1,559 | $131,265 | $68,732 |
Total Patients
5,493
Total Services
7,162
Medicare Billing
$391,623
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 315 | 512 | $54,150 | $36,893 | 68.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 342 | 524 | $55,670 | $35,335 | 63.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 69 | 84 | $12,180 | $8,992 | 73.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 142 | $9,940 | $6,839 | 68.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 118 | 140 | $9,800 | $6,822 | 69.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 49 | $7,105 | $5,613 | 79.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 28 | 28 | $4,620 | $2,549 | 55.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 135 | 151 | $4,530 | $890.50 | 19.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 73 | 80 | $2,400 | $454.29 | 18.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 23 | 23 | $1,150 | $348.39 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 326 | 545 | $57,225 | $38,230 | 66.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 340 | 533 | $56,225 | $37,000 | 65.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 151 | 202 | $14,140 | $9,673 | 68.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 144 | 163 | $11,540 | $7,696 | 66.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 38 | 42 | $6,090 | $4,813 | 79.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 27 | $3,915 | $3,134 | 80.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 31 | 31 | $5,115 | $3,104 | 60.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $3,795 | $2,209 | 58.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2022 | 66 | 66 | $3,300 | $1,051 | 31.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 111 | 116 | $3,480 | $714.67 | 20.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 109 | 119 | $3,570 | $708.03 | 19.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 332 | 451 | $47,485 | $31,793 | 67.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 298 | 436 | $45,910 | $31,668 | 69.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 210 | 285 | $20,340 | $14,366 | 70.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 192 | 254 | $17,790 | $12,346 | 69.4% |
About Dr. Franklin Fleischhauer, MD
Dr. Franklin Fleischhauer, MD is a Cardiovascular Disease healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1275533788.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Franklin Fleischhauer, MD has received a total of $165,601 in payments from pharmaceutical and medical device companies, with $49,431 received in 2024. These payments were reported across 553 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($146,751).
As a Medicare-enrolled provider, Fleischhauer has provided services to 5,493 Medicare beneficiaries, totaling 7,162 services with total Medicare billing of $391,623. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Pensacola, FL
- Active Since 07/26/2005
- Last Updated 03/19/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1275533788
Products in Payments
- JARDIANCE (Drug) $81,256
- PRALUENT (Drug) $36,718
- WATCHMAN Access System (Device) $26,965
- PRALUENT ALIROCUMAB INJECTION (Biological) $5,836
- PRALUENT (Biological) $5,130
- WATCHMAN FLX (Device) $797.48
- ELIQUIS (Drug) $658.48
- Repatha (Biological) $629.83
- XARELTO (Drug) $542.43
- VERQUVO (Drug) $512.78
- CoreValve Evolut (Device) $441.55
- BRILINTA (Drug) $347.08
- ENTRESTO (Drug) $343.21
- LifeVest (Device) $314.48
- CAMZYOS (Drug) $296.43
- WATCHMAN (Device) $272.62
- Impella (Device) $267.69
- LEQVIO (Drug) $244.84
- Cardiac Monitoring Suite (Device) $225.90
- FFRct (Device) $169.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Pensacola
Rohit Amin, Md, MD
Cardiovascular Disease — Payments: $762,056
Cardiovascular Disease $762,056
Mark Grise, Md, MD
Cardiovascular Disease — Payments: $86,692
Cardiovascular Disease $86,692
Sergey Kachur, M.d, M.D
Cardiovascular Disease — Payments: $35,457
Cardiovascular Disease $35,457
Dr. David Woodard, M.d, M.D
Cardiovascular Disease — Payments: $15,339
Cardiovascular Disease $15,339
Dr. Marcelo Branco, Md, MD
Cardiovascular Disease — Payments: $13,222
Cardiovascular Disease $13,222
Licheng Lee, M.d, M.D
Cardiovascular Disease — Payments: $8,409
Cardiovascular Disease $8,409